share_log

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga ·  Nov 7 20:05

Gainers

  • Ensysce Biosciences (NASDAQ:ENSC) shares rose 31.7% to $0.72 during Thursday's pre-market session. The company's market cap stands at $10.8 million.
  • VSee Health (NASDAQ:VSEE) stock increased by 24.03% to $1.6. The market value of their outstanding shares is at $24.5 million.
  • Emergent BioSolutions (NYSE:EBS) shares increased by 22.93% to $11.31. The company's market cap stands at $592.6 million. As per the press release, Q3 earnings came out yesterday.
  • LogicMark (NASDAQ:LGMK) stock rose 20.4% to $0.12. The company's market cap stands at $1.3 million.
  • China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) stock increased by 18.14% to $0.26.
  • Syra Health (NASDAQ:SYRA) stock rose 17.25% to $0.49. The company's market cap stands at $4.8 million.

Losers

  • Sutro Biopharma (NASDAQ:STRO) shares decreased by 15.5% to $3.5 during Thursday's pre-market session. The company's market cap stands at $286.8 million.
  • Plus Therapeutics (NASDAQ:PSTV) shares decreased by 14.69% to $1.22. The market value of their outstanding shares is at $7.1 million.
  • Clover Health Investments (NASDAQ:CLOV) stock decreased by 9.89% to $3.92. The market value of their outstanding shares is at $1.9 billion. As per the press release, Q3 earnings came out yesterday.
  • Esperion Therapeutics (NASDAQ:ESPR) shares fell 9.51% to $2.0. The market value of their outstanding shares is at $392.4 million. As per the news, the Q3 earnings report came out today.
  • Personalis (NASDAQ:PSNL) stock fell 9.14% to $5.07. The company's market cap stands at $334.2 million. As per the news, the Q3 earnings report came out yesterday.
  • SenesTech (NASDAQ:SNES) stock decreased by 8.78% to $2.6. The market value of their outstanding shares is at $2.6 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment